Adaptability of High Dimensional Propensity Score Procedure in the Transition from ICD-9 to ICD-10 in the US Healthcare System

References

• Prada-Ramallal G, Takkouche B, Figueiras A. Bias in pharmacoepidemiologic studies using secondary health care databases: a scoping review. BMC Med Res Methodol. 2019;19(1):53. doi:10.1186/s12874-019-0695-y
   PubMedGoogle Scholar
• Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol. 2005;58(4):323–337. doi:10.1016/j.jclinepi.2004.10.012
   PubMed Web of Science ®Google Scholar
• Connolly JG, Glynn RJ, Schneeweiss S, Gagne JJ. Improving measurement of binary covariates in claims data: a simulation study. Pharmacoepidemiol Drug Saf. 2020;29(9):1093–1100. doi:10.1002/pds.4961
   PubMed Web of Science ®Google Scholar
• Cuthbertson CC, Kucharska-Newton A, Faurot KR, et al. Controlling for frailty in pharmacoepidemiologic studies of older adults: validation of an existing medicare claims-based algorithm. Epidemiology. 2018;29(4):556–561. doi:10.1097/EDE.0000000000000833
   PubMed Web of Science ®Google Scholar
• Patorno E, Gopalakrishnan C, Franklin JM, et al. Claims-based studies of oral glucose-lowering medications can achieve balance in critical clinical variables only observed in electronic health records. Diabetes Obes Metab. 2018;20(4):974–984. doi:10.1111/dom.13184
   PubMed Web of Science ®Google Scholar
• Mayer SE, Tan HJ, Hinton SP, et al. Comparison of medicare claims-based proxy measures of poor function and associations with treatment receipt and mortality in older colon cancer patients. Med Care. 2019;57(4):286–294. doi:10.1097/MLR.0000000000001073
   PubMed Web of Science ®Google Scholar
• Kuroki M, Pearl J. Measurement bias and effect restoration in causal inference. Biometrika. 2014;101(2):423–437. doi:10.1093/biomet/ast066
   Web of Science ®Google Scholar
• Miao W, Geng Z, Tchetgen Tchetgen EJ. Identifying causal effects with proxy variables of an unmeasured confounder. Biometrika. 2018;105(4):987–993. doi:10.1093/biomet/asy038
   PubMed Web of Science ®Google Scholar
• VanderWeele TJ. Principles of confounder selection. Eur J Epidemiol. 2019;34(3):211–219. doi:10.1007/s10654-019-00494-6
   PubMed Web of Science ®Google Scholar
• Schneeweiss S, Rassen JA, Glynn RJ, Avorn J, Mogun H, Brookhart MA. High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology. 2009;20(4):512–522. doi:10.1097/EDE.0b013e3181a663cc
   PubMed Web of Science ®Google Scholar
• Schneeweiss S. Automated data-adaptive analytics for electronic healthcare data to study causal treatment effects. Clin Epidemiol. 2018;10:771–788. doi:10.2147/CLEP.S166545
   PubMed Web of Science ®Google Scholar
• Rassen JA, Schneeweiss S. Using high-dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance system. Pharmacoepidemiol Drug Saf. 2012;21 Suppl 1:41–49. doi:10.1002/pds.2328
   PubMed Web of Science ®Google Scholar
• Center for Disease Prevention and Control. The ICD-10 transition and public health surveillance - what you need to know; 2013. Available from: https://www.cdc.gov/nchs/icd/icd10cm_pcs_background.htm. Accessed May 16, 2023.
   Google Scholar
• Rassen JA, Seeger J. Propensity scores in pharmacoepidemiology workshop. 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; 2020.
   Google Scholar
• National Library of Medicine. Systematized Nomenclature of Medicine–Clinical Terms (SNOMED CT). Available from: https://www.nlm.nih.gov/healthit/snomedct/index.html. Accessed May 16, 2023.
   Google Scholar
• Agency for Healthcare Research and Quality. Clinical classifications software (CCS) for ICD-9-CM - healthcare cost and utilization project (HCUP); 2017. Available from: https://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp. Accessed May 16, 2023.
   Google Scholar
• Le HV, Poole C, Brookhart A, et al. Effects of aggregation of drug and diagnostic codes on the performance of the high-dimensional propensity score algorithm: an empirical example. BMC Med Res Methodol. 2013;13(1). doi:10.1186/1471-2288-13-142
   PubMedGoogle Scholar
• Mallen SR, Essex MN, Zhang R. Gastrointestinal tolerability of NSAIDs in elderly patients: a pooled analysis of 21 randomized clinical trials with celecoxib and nonselective NSAIDs. Curr Med Res Opin. 2011;27(7):1359–1366. doi:10.1185/03007995.2011.581274
   PubMed Web of Science ®Google Scholar
• Eisen GM, Goldstein JL, Hanna DB, Rublee DA. Meta-analysis: upper gastrointestinal tolerability of valdecoxib, a cyclooxygenase-2-specific inhibitor, compared with nonspecific nonsteroidal anti-inflammatory drugs among patients with osteoarthritis and rheumatoid arthritis. Aliment Pharmacol Ther. 2005;21(5):591–598. doi:10.1111/j.1365-2036.2005.02383.x
   PubMed Web of Science ®Google Scholar
• Watson DJ, Harper SE, Zhao PL, Quan H, Bolognese JA, Simon TJ. Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis. Arch Intern Med. 2000;160(19):2998–3003. doi:10.1001/archinte.160.19.2998
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration - Sentinel Initiative. Gastrointestinal bleeding algorithm defined in “thromboembolic stroke, intracranial hemorrhage, gastrointestinal bleeding, and major extracranial bleeding following dabigatran, rivaroxaban, and apixaban use in patients with atrial fibrillation: a propensity score matched analysis; 2020 https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/gastrointestinal-bleeding-algorithm-defined.
   Google Scholar
• Raiford DS, Pérez Gutthann S, García Rodríguez LA. Positive predictive value of ICD-9 codes in the identification of cases of complicated peptic ulcer disease in the Saskatchewan hospital automated database. Epidemiology. 1996;7(1):101–104. doi:10.1097/00001648-199601000-00018
   PubMed Web of Science ®Google Scholar
• Wyss R, Fireman B, Rassen JA, Schneeweiss S. Erratum: high-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology. 2018;29(6):e63–e64. doi:10.1097/EDE.0000000000000886
   PubMed Web of Science ®Google Scholar
• Brookhart MA, Schneeweiss S, Rothman KJ, Glynn RJ, Avorn J, Stürmer T. Variable selection for propensity score models. Am J Epidemiol. 2006;163(12):1149–1156. doi:10.1093/AJE/KWJ149
   PubMed Web of Science ®Google Scholar
• Patrick AR, Schneeweiss S, Brookhart MA, et al. The implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustration. Pharmacoepidemiol Drug Saf. 2011;20(6):551–559. doi:10.1002/PDS.2098
   PubMed Web of Science ®Google Scholar
• Patorno E, Glynn RJ, Hernández-Díaz S, Liu J, Schneeweiss S. Studies with many covariates and few outcomes: selecting covariates and implementing propensity-score-based confounding adjustments. Epidemiology. 2014;25(2):268–278. doi:10.1097/EDE.0000000000000069
   PubMed Web of Science ®Google Scholar
• Wyss R, Glynn RJ, Gagne JJ. A review of disease risk scores and their application in pharmacoepidemiology. Curr Epidemiol Reports. 2016;3(4):277–284. doi:10.1007/S40471-016-0088-2
   Google Scholar
• Mack CD, Glynn RJ, Brookhart MA, et al. Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy. Pharmacoepidemiol Drug Saf. 2013;22(8):810–818. doi:10.1002/PDS.3386
   PubMed Web of Science ®Google Scholar
• Seeger JD, Kurth T, Walker AM, Use of propensity score technique to account for exposure-related covariates: an example and lesson. Med Care. 2007;45(10):S143–S148. doi:10.1097/MLR.0b013e318074ce79
   PubMed Web of Science ®Google Scholar
• Agency for Healthcare Research and Quality. Clinical Classifications Software Refined (CCSR) - healthcare cost and utilization program (HCUP). Available from: https://www.hcup-us.ahrq.gov/toolssoftware/ccsr/ccs_refined.jsp. Accessed February 1, 2022.
   Google Scholar
• Franklin JM, Schneeweiss S, Polinski JM, Rassen JA. Plasmode simulation for the evaluation of pharmacoepidemiologic methods in complex healthcare databases. Comput Stat Data Anal. 2014;72:219–226. doi:10.1016/j.csda.2013.10.018
   PubMed Web of Science ®Google Scholar